01-12-2021 | Polymyositis | Brief Report
Perspectives on glucocorticoid usage in patients with adult inflammatory myopathy
Published in: Clinical Rheumatology | Issue 12/2021
Login to get accessAbstract
Key Points • Glucocorticoids (GC) are the first-line treatment in patients with idiopathic inflammatory myopathies (IIM), and are associated with a wide range of adverse effects • The adverse effects related to GC are very common, and those reported most severe by patients included weight gain, moon face, increased hunger or sleep disturbance, which may differ from the primary concerns of their treating clinician • Understanding the patient perspective and concerns about treatment is necessary to maintain a good physician–patient relationship and may help with treatment adherence |